Skip to main content

United States Tuberculosis Drug Market Report 2017 (First-line anti-TB drugs and Second-line anti-TB drugs) by Type and Application, Forecast to 2022

Press Release   •   Aug 31, 2017 04:07 EDT

In this report, the United States Tuberculosis Drug Market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Click Here To Get Request Sample: http://globalqyresearch.com/download-sample/263551 

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Tuberculosis Drug in these regions, from 2012 to 2022 (forecast).

United States Tuberculosis Drug market competition by top manufacturers/players, with Tuberculosis Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Lupin
Otsuka Novel Products
Pfizer
Sandoz
Sanofi
AstraZeneca
Archivel Farma
EIKEN CHEMICAL
Cepheid
Epistem

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Active TB
Latent TB

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Tuberculosis Drug for each application, including
First-line anti-TB drugs
Second-line anti-TB drugs

Ask Query Here:Jay@globalqyresearch.com or Sales@globalqyresearch.com

Table of Contents

United States Tuberculosis Drug Market Report 2017
1 Tuberculosis Drug Overview
1.1 Product Overview and Scope of Tuberculosis Drug
1.2 Classification of Tuberculosis Drug by Product Category
1.2.1 United States Tuberculosis Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Tuberculosis Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Active TB
1.2.4 Latent TB
1.3 United States Tuberculosis Drug Market by Application/End Users
1.3.1 United States Tuberculosis Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 First-line anti-TB drugs
1.3.3 Second-line anti-TB drugs
1.4 United States Tuberculosis Drug Market by Region
1.4.1 United States Tuberculosis Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Tuberculosis Drug Status and Prospect (2012-2022)
1.4.3 Southwest Tuberculosis Drug Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Tuberculosis Drug Status and Prospect (2012-2022)
1.4.5 New England Tuberculosis Drug Status and Prospect (2012-2022)
1.4.6 The South Tuberculosis Drug Status and Prospect (2012-2022)
1.4.7 The Midwest Tuberculosis Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Tuberculosis Drug (2012-2022)
1.5.1 United States Tuberculosis Drug Sales and Growth Rate (2012-2022)
1.5.2 United States Tuberculosis Drug Revenue and Growth Rate (2012-2022)

2 United States Tuberculosis Drug Market Competition by Players/Suppliers
2.1 United States Tuberculosis Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Tuberculosis Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Tuberculosis Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Tuberculosis Drug Market Competitive Situation and Trends
2.4.1 United States Tuberculosis Drug Market Concentration Rate
2.4.2 United States Tuberculosis Drug Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Tuberculosis Drug Manufacturing Base Distribution, Sales Area, Product Type

3 United States Tuberculosis Drug Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Tuberculosis Drug Sales and Market Share by Region (2012-2017)
3.2 United States Tuberculosis Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Tuberculosis Drug Price by Region (2012-2017)

4 United States Tuberculosis Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Tuberculosis Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Tuberculosis Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Tuberculosis Drug Price by Type (2012-2017)
4.4 United States Tuberculosis Drug Sales Growth Rate by Type (2012-2017)

5 United States Tuberculosis Drug Sales (Volume) by Application (2012-2017)
5.1 United States Tuberculosis Drug Sales and Market Share by Application (2012-2017)
5.2 United States Tuberculosis Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Tuberculosis Drug Players/Suppliers Profiles and Sales Data
6.1 Lupin
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Tuberculosis Drug Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Lupin Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Otsuka Novel Products
6.2.2 Tuberculosis Drug Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Otsuka Novel Products Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Pfizer
6.3.2 Tuberculosis Drug Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Pfizer Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Sandoz
6.4.2 Tuberculosis Drug Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Sandoz Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Sanofi
6.5.2 Tuberculosis Drug Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Sanofi Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 AstraZeneca
6.6.2 Tuberculosis Drug Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 AstraZeneca Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Archivel Farma
6.7.2 Tuberculosis Drug Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Archivel Farma Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 EIKEN CHEMICAL
6.8.2 Tuberculosis Drug Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 EIKEN CHEMICAL Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Cepheid
6.9.2 Tuberculosis Drug Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Cepheid Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Epistem
6.10.2 Tuberculosis Drug Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Epistem Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Tuberculosis Drug Manufacturing Cost Analysis
7.1 Tuberculosis Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Tuberculosis Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Tuberculosis Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Tuberculosis Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Tuberculosis Drug Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Tuberculosis Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Tuberculosis Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Tuberculosis Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Tuberculosis Drug Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

To Purchase this Premium Report: http://globalqyresearch.com/checkout-form/0/263551

About Us:

Global QYResearch is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Browse Our Pharma Blog:http://pharmainvestmentnews.com/

Contact Us:

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom

Contact: +44 20 3239 2407

Comments (0)

Add comment

Comment